ClinicalAtrial fibrillationAtrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation
Introduction
Obstructive sleep apnea (OSA) is increasingly recognized as a potential risk factor for the development of atrial fibrillation (AF).1, 2, 3 In addition, OSA has been associated with a greater risk of recurrence of AF after cardioversion4 and catheter ablation.5 Despite the enormity of the problems associated with the epidemic of AF, the mechanisms by which OSA predisposes to the development or recurrence of AF remains unknown. Recent evidence has highlighted the importance of atrial structural and electrical remodeling in the substrate predisposing to AF.6, 7, 8, 9, 10, 11, 12, 13 We postulated that patients with OSA have evidence of atrial structural and electrical remodeling to account for their predisposition to AF.
Section snippets
Study population
The study comprised 40 patients undergoing first-time ablation of paroxysmal AF. These patients were dichotomized by polysomnography into OSA (moderate to severe OSA: apnea–hypopnea index ≥ 15; n = 20) and a reference group (none to mild OSA: apnea–hypopnea index < 15; n = 20). Patients with significant central sleep apnea were excluded from the study. A total of 96 consecutive patients were screened to obtain 40 patients fulfilling the study criteria. To avoid the remodeling due to arrhythmia
Baseline characteristics
Baseline characteristics are summarized in Table 1. There were no significant differences in the use of β-blockers (P = .3), calcium-channel blockers (P = .5), or angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers (P = .7) between the groups. Patients with OSA demonstrated significantly larger atria indexed to body surface area (P = .009). Left ventricular function was normal for all patients. University of Toronto AFSS duration and frequency scores were similar between the
Major findings
This study utilized detailed electrophysiologic and electroanatomic mapping to characterize electrophysiologic and electroanatomic atrial abnormalities in patients with OSA. Those with OSA demonstrated the following compared with reference patients:
- 1
Structural change with increased atrial size and extensive areas of low voltage and regions of electrical silence, perhaps suggesting loss of atrial myocardium, fibrosis, or underlying conduction dissociation.
- 2
Conduction abnormalities characterized
Conclusion
Patients with OSA demonstrate significant atrial remodeling characterized by structural abnormalities with a reduction in atrial myocardial voltage regions of electrical silence, conduction slowing, and sinus node dysfunction. These factors may account for the development and maintenance of AF in patients with OSA.
References (35)
- et al.
Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome
Am J Cardiol
(1983) - et al.
Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation
Am J Cardiol
(2011) - et al.
Electrophysiologic and electroanatomic changes in the human atrium associated with age
J Am Coll Cardiol
(2004) - et al.
Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the “second factor.”
J Am Coll Cardiol
(2009) - et al.
Left atrial remodeling in patients with atrial septal defects
Heart Rhythm
(2009) - et al.
Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model
Heart Rhythm
(2010) - et al.
Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model
Heart Rhythm
(2010) - et al.
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy
J Am Coll Cardiol
(2000) - et al.
Triggering of nocturnal arrhythmias by sleep-disordered breathing events
J Am Coll Cardiol
(2009) - et al.
Mechanism of initiation of atrial flutter in humans: site of unidirectional block and direction of rotation
J Am Coll Cardiol
(1997)
Dynamic changes of left ventricular performance and left atrial volume induced by the Mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure
Am J Cardiol
Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea
Heart Rhythm
Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation
Heart Rhythm
Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea
Heart Rhythm
Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure
J Am Coll Cardiol
Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function
Eur Heart J
Association of atrial fibrillation and obstructive sleep apnea
Circulation
Cited by (255)
Aging and atrial fibrillation: A vicious circle
2024, International Journal of CardiologyAssociation between sick sinus syndrome and atrial fibrillation: A systematic review and meta-analysis
2023, International Journal of Cardiology
Dr Dimitri is supported by Postgraduate Medical Scholarships from the Cardiac Society of Australia and New Zealand and jointly by the National Heart Foundation of Australia and the National Health and Medical Research Council of Australia. Dr Brooks, Dr Kuklik, and Dr Sanders are funded by the National Heart Foundation of Australia. Dr Stiles is supported by the National Heart Foundation of New Zealand and the Dawes Scholarship from the Royal Adelaide Hospital. Dr Lau is supported by a Postdoctoral Fellowship from the National Health and Medical Research Council of Australia. Dr Sanders reports having served on the advisory board of Bard Electrophysiology, Biosense-Webster, Medtronic, St Jude Medical, Sanofi-Aventis, and Merck, Sharpe and Dohme. Dr Sanders reports having received lecture fees and research funding from Bard Electrophysiology, Biosense-Webster, Medtronic, and St Jude Medical.